NF-kappaB signalling: embracing complexity to achieve translation.

Area of Science:

• Hepatology
• Molecular Biology
• Immunology

Background:

• Nuclear factor kappa B (NF-kappaB) is a key transcription factor involved in liver homeostasis.
• Dysregulation of NF-kappaB is implicated in liver diseases such as hepatitis, steatosis, fibrosis, and hepatocellular carcinoma.

Purpose of the Study:

• To critically evaluate the therapeutic potential of targeting NF-kappaB in diseased human livers.
• To question the current focus on upstream inhibitor of kappaB kinase (IKK) complex components as therapeutic targets.

Main Methods:

• Review of experimental evidence on NF-kappaB in liver pathologies.
• Critical analysis of current therapeutic strategies targeting the IKK complex.
• Examination of NF-kappaB/Rel subunit functions, post-translational modifications, and co-regulator interactions.

Main Results:

• Evidence suggests that targeting the IKK complex may not be the optimal therapeutic strategy for liver diseases.
• NF-kappaB's role in liver homeostasis and pathology is complex and context-dependent.

Conclusions:

• Translating NF-kappaB biology into effective therapies requires a shift in research focus.
• Future therapeutic development should prioritize understanding NF-kappaB/Rel subunit functions and their regulatory mechanisms.